Letter to the editor on the paper: 'The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing'

Sehr Tony; Proschmann Undine; Thomas Katja; Ziemssen Tjalf

首页> 外文期刊>Multiple sclerosis: clinical and laboratory research >Letter to the editor on the paper: 'The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing'

【24h】

Letter to the editor on the paper: 'The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing'

机译：撰写本文的函件：“大多数Natalizumab治疗的MS患者在重塑时具有高幼稚素浓度”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Multiple sclerosis: clinical and laboratory research》 |2018年第6期|共3页
作者
Sehr Tony; Proschmann Undine; Thomas Katja; Ziemssen Tjalf;
展开▼
作者单位

Univ Hosp Carl Gustav Carus Dept Neurol Ctr Clin Neurosci MS Ctr Fetscherstr 74 D-01307;

Univ Hosp Carl Gustav Carus Dept Neurol Ctr Clin Neurosci MS Ctr Fetscherstr 74 D-01307;

Univ Hosp Carl Gustav Carus Dept Neurol Ctr Clin Neurosci MS Ctr Fetscherstr 74 D-01307;

Univ Hosp Carl Gustav Carus Dept Neurol Ctr Clin Neurosci MS Ctr Fetscherstr 74 D-01307;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing" [J] . van Kempen Zoe L. E., Rispens Theo, Killestein Joep Multiple sclerosis: clinical and laboratory research . 2018,第6期

机译：回应“论文中的编辑函：大多数Natalizumab治疗的MS患者在重新定量时具有高幼稚素浓度”
2. Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing" [J] . Sehr Tony, Proschmann Undine, Thomas Katja, Multiple sclerosis: clinical and laboratory research . 2018,第6期

机译：撰写本文的函件：“大多数Natalizumab治疗的MS患者在重塑时具有高幼稚素浓度”
3. Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing" [J] . van Kempen Zoe L. E., Rispens Theo, Killestein Joep Multiple sclerosis: clinical and laboratory research . 2018,第6期

机译：回应“论文中的编辑函：大多数Natalizumab治疗的MS患者在重新定量时具有高幼稚素浓度”
4. Letter to the editor: Correction to “Analysis of time delay difference due to parametric mismatch in matched filter channels” [C] . Stuarts Guillermo, Julian Pedro 2012 Argentine School of Micro-Nanoelectronics, Technology and Applications . 2012

机译：致编辑的信：对“由于匹配滤波器通道中的参数不匹配导致的时延差异分析”的更正
5. Determination of the Levels and Concentrations of the Most Used Autism Spectrum Disorder Medications (Olanzapine, Risperidone and Quetiapine) in Autistic Patient’s Plasma by Using Lc/Ms/Ms [D] . Fraih, Dana Fayez. 2020

机译：通过使用LC / MS / MS测定自闭症患者血浆中最常用的自闭症谱系药物（Olanzapine，Risperidone和Quetiapine）的水平和浓度
6. Response to Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing [O] . Zoé LE van Kempen, Theo Rispens, Joep Killestein -1

机译：对给纸上编辑的信：大多数接受那他珠单抗治疗的MS患者在重新给药时那他珠单抗浓度很高的答复
7. Brainstem PML lesion mimicking\ud MS plaque in a natalizumab-treated MS patient. [O] . Tortorella C, Direnzo V, D'Onghia M, 2013

机译：模拟的脑干PML病变\ ud 那他珠单抗治疗的MS患者的MS斑块。

Letter to the editor on the paper: 'The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing'

著录项

相似文献

相关主题

期刊订阅